Name
Biofortuna
Company Description
Biofortuna is a specialist diagnostic contract assay development and manufacturing organisation (diagnostic CDMO ) providing a flexible and scalable outsourcing service to the sector’s leading in-vitro and point-of-care assay developers.
Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 13485 certification, ISO 17025 accreditation and FDA registration, they have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.
Services include assay design, assay optimization, lyophilization (lyophilisation), lyophilized beads (lyo beads); assay scale-up; design for manufacture and assay manufacture.
Product Categories
Contract Manufacturing, Custom Manufacturing, Abused Drug Testing, Alcohol Testing, Animal Diagnostics, Cancer Testing, Cardiac Testing, COVID, Drug Testing, Enzyme Testing, Genetic Screening, Genetic Testing, Genomics, Infectious Disease Testing, Molecular Diagnostics, Near Patient Testing, Platelets, Point of Care Testing, STD Testing, Capillary Electrophoresis, ELISA, Immunoassay Systems, Lyophilization, DNA Extraction, DNA Viral Testing, Contract Development, Product Development/Services, Custom Development
Featured Exhibitor
Yes
Will you have new products this year?
Yes
Address
2 Tenth Avenue
Deeside Industrial Park
Deeside, CH5 2UA
United Kingdom
Instagram
LinkedIn
X

Listings

Relevance
Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day
UK Diagnostic CDMO boosts Lyo bead output threefold with bespoke robotic manufacturing and QC system

Videos

Relevance

Share: